Primary |
Acarodermatitis |
60.0% |
Infection Parasitic |
20.0% |
Infestation |
20.0% |
|
Drug Ineffective |
30.0% |
Adverse Drug Reaction |
10.0% |
Dizziness |
10.0% |
Malaise |
10.0% |
Neoplasm Malignant |
10.0% |
Rash Erythematous |
10.0% |
Skin Atrophy |
10.0% |
Throat Irritation |
10.0% |
|
Secondary |
Rheumatoid Arthritis |
17.9% |
Bronchitis Chronic |
9.0% |
Gastritis |
9.0% |
Fungal Infection |
6.0% |
Pruritus |
6.0% |
Seborrhoeic Dermatitis |
6.0% |
Cerebral Infarction |
4.5% |
Hypertension |
4.5% |
Itchy Rash |
4.5% |
Osteoporosis Prophylaxis |
4.5% |
Prophylaxis Against Gastrointestinal Ulcer |
4.5% |
Rash Pruritic |
4.5% |
Acarodermatitis |
3.0% |
Ankle Sprain |
3.0% |
Dermatitis Infected |
3.0% |
Drug Use For Unknown Indication |
3.0% |
Ligament Sprain |
3.0% |
Swelling |
3.0% |
Itching |
1.5% |
|
Skin Test Positive |
27.3% |
Compression Fracture |
18.2% |
Skin Exfoliation |
18.2% |
Enterocolitis |
9.1% |
Lymphocyte Stimulation Test Positive |
9.1% |
Off Label Use |
9.1% |
Renal Disorder |
9.1% |
|
Concomitant |
Product Used For Unknown Indication |
12.8% |
Prophylaxis |
11.6% |
Acarodermatitis |
10.8% |
Rheumatoid Arthritis |
9.0% |
Psoriasis |
8.3% |
Rash |
6.8% |
Pruritus |
6.2% |
Hypertension |
5.4% |
Insomnia |
3.4% |
Metastatic Renal Cell Carcinoma |
3.3% |
Pancreatic Neuroendocrine Tumour |
3.1% |
Postoperative Care |
3.1% |
Constipation |
2.5% |
Rhinitis Allergic |
2.5% |
Pyrexia |
2.2% |
Gastritis |
1.9% |
Chronic Myeloid Leukaemia |
1.9% |
Eczema |
1.8% |
Hepatic Neoplasm Malignant |
1.8% |
Hepatitis C |
1.8% |
|
Pyrexia |
9.8% |
Syncope |
9.8% |
Breast Mass |
6.8% |
Peritonitis Bacterial |
6.8% |
Pneumonia |
6.1% |
Renal Impairment |
6.1% |
Subileus |
5.3% |
Cardio-respiratory Arrest |
4.5% |
Rash |
4.5% |
Sepsis |
4.5% |
Shock |
4.5% |
Cardiac Failure |
3.8% |
Colonic Stenosis |
3.8% |
Liver Disorder |
3.8% |
Pneumonia Aspiration |
3.8% |
Scrotal Oedema |
3.8% |
Angina Pectoris |
3.0% |
Decreased Appetite |
3.0% |
Haematuria |
3.0% |
Haemoglobin Decreased |
3.0% |
|